Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vaxcyte, Inc.(PCVX) | 1,425,470 | 1,425,470 | 0 | $82.86M | $81.11M | 32.22% | -$1.75M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 1,265,283 | 1,008,174 | -257,109 | $33.18M | $26.65M | 10.58% | -$6.53M |
| Trevi Therapeutics, Inc.(TRVI) | 1,742,672 | 1,742,672 | 0 | $32.50M | $24.96M | 9.91% | -$7.55M |
| Avalyn Pharmaceuticals Inc | 966,792 | 866,792 | -100,000 | $31.83M | $24.69M | 9.81% | -$7.13M |
| Evommune, Inc.(EVMN) | 1,926,943 | 1,926,943 | 0 | $25.61M | $15.92M | 6.32% | -$9.69M |
| Immunome, Inc.(IMNM) | 732,512 | 732,512 | 0 | $15.52M | $15.76M | 6.26% | +$234.4K |
| Oculis Holding AG(OCS) | 1,506,250 | 1,658,907 | +152,657 | $20.89M | $15.49M | 6.15% | -$5.40M |
| Obsidian Therapeutics Inc | 0 | 860,343 | +860,343 | $0 | $11.81M | 4.69% | +$11.81M |
| Avalo Therapeutics, Inc.(AVTX) | 434,033 | 434,033 | 0 | $8.02M | $6.65M | 2.64% | -$1.37M |
| Braveheart Bio Inc | 0 | 317,351 | +317,351 | $0 | $6.41M | 2.55% | +$6.41M |
| Zenas BioPharma, Inc.(ZBIO) | 490,766 | 233,176 | -257,590 | $12.46M | $6.29M | 2.50% | -$6.17M |
| MapLight Therapeutics, Inc.(MPLT) | 611,446 | 611,446 | 0 | $21.91M | $6.23M | 2.47% | -$15.68M |
| Rallybio Corporation(RLYB) | 300,579 | 300,579 | 0 | $4.81M | $5.17M | 2.05% | +$360.7K |
| BioAge Labs, Inc.(BIOA) | 653,374 | 653,374 | 0 | $16.01M | $4.63M | 1.84% | -$11.38M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 595,518 | 0 | -595,518 | $2.19M | $0 | — | -$2.19M |